Related Experiment Video

Updated: May 11, 2026

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae
15:12

Purification of the Cystic Fibrosis Transmembrane Conductance Regulator Protein Expressed in Saccharomyces cerevisiae

Published on: May 10, 2014

CFTR expression and organ damage in cystic fibrosis

E F Tizzano1, M Buchwald

  • 1Hospital de la Santa Creu i Sant Pau, Barcelona, Spain.

Annals of Internal Medicine
|August 15, 1995
PubMed

Insights

Cystic fibrosis (CF) organ damage stems from a combination of CFTR gene mutations, chloride secretion rates, and organ-specific anatomy. Understanding these factors is key to preventing disease progression.

Area of Science:

  • Genetics
  • Molecular Biology
  • Pathophysiology

Background:

  • The cloning of the cystic fibrosis transmembrane regulator (CFTR) gene has advanced understanding of cystic fibrosis (CF) pathogenesis.
  • Despite progress, the fundamental defect and disease mechanisms remain incompletely understood.
  • Existing research offers insights into molecular defects, gene expression, and CFTR function.

Purpose of the Study:

  • To elucidate the multifactorial pathogenesis of organ damage in cystic fibrosis.
  • To propose a unifying hypothesis integrating genetic, functional, and anatomical factors in CF.
  • To provide a framework for improved understanding and prevention of CF-related organ damage.

Main Methods:

  • Hypothesis formulation based on existing literature.
  • Analysis of genotype-phenotype correlations in CF.
  • Inference of CFTR-mediated chloride secretion rates from gene expression data.
  • Consideration of anatomical and physiological characteristics of affected organs.

Main Results:

  • Organ damage in CF is hypothesized to result from a synergistic interplay of three primary factors.
  • Factor 1: Genotype, specifically the type of mutation affecting CFTR protein function.
  • Factor 2: Rate of CFTR-mediated chloride secretion, influenced by gene expression levels in epithelial cells.
  • Factor 3: Anatomical and physiological traits of affected organs, including duct size and content.

Conclusions:

  • The proposed hypothesis offers a comprehensive model for CF pathogenesis.
  • Confirmation of this model can significantly enhance the understanding of how CF affects various organs.
  • This improved understanding is crucial for developing targeted strategies to prevent organ damage in cystic fibrosis patients.

More Related Videos

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients07:04

Forskolin-induced Swelling in Intestinal Organoids: An In Vitro Assay for Assessing Drug Response in Cystic Fibrosis Patients

Published on: February 11, 2017

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis05:56

Implementation of Non-invasive Point of Care Transient Elastography for Evaluation of Liver Disease in Pediatric Populations with Cystic Fibrosis

Published on: August 29, 2025

Related Concept Videos

Mutations01:39

Mutations

Overview
Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic sinusitis...
Chronic Pancreatitis I: Introduction01:24

Chronic Pancreatitis I: Introduction

The pancreas, an elongated and flat gland situated behind the stomach, serves a vital function in digesting food and managing blood sugar levels.
Pancreatitis is the inflammation of the pancreas, which occurs when the immune system becomes active and causes swelling, pain, and disruptions in organ function. Pancreatitis can manifest as either an acute or chronic condition.
Acute pancreatitis arises suddenly and lasts for a brief duration, while chronic pancreatitis is a long-term affliction...
Cirrhosis II: Pathophysiology01:24

Cirrhosis II: Pathophysiology

Cirrhosis is a progressive chronic liver injury caused by prolonged inflammation, excessive fibrotic remodeling, and impaired regeneration. Over time, repeated hepatic insults disrupt the liver’s architecture and function, leading to reduced blood flow, impaired bile drainage, and diminished metabolic capacity.Pathophysiology of cirrhosisCirrhosis arises from three main responses to chronic liver damage: inflammation, immune activation, and hepatocyte death. These processes lead to structural...
Chronic Pancreatitis I: Introduction01:25

Chronic Pancreatitis I: Introduction

Chronic pancreatitis is a long-standing, relapsing inflammation of the pancreas, characterized by irreversible damage to the gland. It results in progressive destruction of the pancreatic parenchyma, fibrosis, and eventual loss of both exocrine and endocrine function. The disease may evolve gradually after multiple episodes of acute pancreatitis or develop independently.EtiologyChronic pancreatitis can arise from a variety of causes:Alcohol use is the leading cause, accounting for 70–80% of...